TABLE 1.
Parameter | kel | t1/2 | Tmax | Cmax | AUC0-t | AUC0-∞ | AUMC0-t | AUMC0-∞ | MRT0-t | MRT0-∞ | Vz/F | Cl/F |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1/min | min | min | ng/ml | ng•min/l | ng•min/l | ng•min2/l | ng•min2/l | min | min | l/kg | (l/min)/kg | |
Plasma | ||||||||||||
Netamine | ||||||||||||
Male | 0.0156 | 44.42 | 5 | 100.52 | 2.86 | 3.10 | 127.52 | 186.09 | 44.60 | 60.05 | 51.69 | 0.807 |
Female | 0.0116 | 59.99 | 5 | 135.83 | 5.48 | 6.07 | 276.24 | 434.03 | 50.45 | 71.53 | 35.66 | 0.412 |
Norketamine | ||||||||||||
Male | 0.0124 | 55.76 | 30 | 190.68 | 14.54 | 16.85 | 808.15 | 1409.02 | 55.58 | 83.63 | 11.94 | 0.148 |
Female | 0.0095 | 72.72 | 30 | 311.80 | 28.04 | 34.41 | 1937.45 | 3751.16 | 69.10 | 109.03 | 7.62 | 0.073 |
Dehydronorketamine | ||||||||||||
Male | — | — | 30 | 9.88 | 0.61 | — | 38.48 | — | 62.67 | — | — | — |
Female | — | — | 90 | 5.49 | 0.66 | — | 62.28 | — | 94.02 | — | — | — |
mPFC | ||||||||||||
Ketamine | ||||||||||||
Male | 0.0471 | 14.72 | 5 | 198.47 | 9.09 | — | 288.26 | — | 31.72 | — | — | — |
Female | 0.0504 | 13.74 | 10 | 402.87 | 10.92 | — | 274.57 | — | 25.15 | — | — | — |
Norketamine | ||||||||||||
Male | 0.0223 | 31.08 | 10 | 170.64 | 9.78 | — | 405.59 | — | 41.45 | — | — | — |
Female | 0.0170 | 40.66 | 10 | 413.26 | 26.07 | — | 1233.84 | — | 47.33 | — | — | — |
HPC | ||||||||||||
Ketamine | ||||||||||||
Male | 0.0487 | 14.24 | 10 | 199.21 | 9.12 | — | 289.12 | — | 31.70 | — | — | — |
Female | 0.0503 | 13.78 | 10 | 375.79 | 10.72 | — | 277.72 | — | 25.91 | — | — | — |
Norketamine | ||||||||||||
Male | 0.0239 | 29.01 | 10 | 170.25 | 9.10 | — | 355.52 | — | 39.06 | — | — | — |
Female | 0.0163 | 42.42 | 10 | 374.46 | 21.69 | — | 1043.47 | — | 48.12 | — | — | — |
AUMC, area under the first moment concentration-time curve; Tmax, time to reach Cmax; MRT, mean residence time; —, n/a.